Nuvectis Pharma
NVCT
NVCT
33 hedge funds and large institutions have $20M invested in Nuvectis Pharma in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 31 → 33 (+2)
1.92% more ownership
Funds ownership: 6.84% → 8.75% (+1.9%)
Holders
33
Holding in Top 10
–
Calls
$1.3M
Puts
$895K
Top Buyers
| 1 | +$2.48M | |
| 2 | +$1.39M | |
| 3 | +$1.06M | |
| 4 |
Millennium Management
New York
|
+$893K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$548K |
Top Sellers
| 1 | -$837K | |
| 2 | -$247K | |
| 3 | -$166K | |
| 4 |
Squarepoint
New York
|
-$78.7K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$34.1K |